Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration, Age-related, 10”

6 trials

Showing 6 of 6 results

Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Not applicableUnknownNCT04607369
What this trial is testing

Implementation of the NEDS EyeCTester App

Who this might be right for
Optic Nerve DiseaseMacular DiseaseVisual Pathway Disorder
Neuro-Eye Diagnostic Systems, LLC 100
Not applicableStudy completedNCT01524874
What this trial is testing

Comparative Effectiveness of Vitamin D and Repletion Strategies

Who this might be right for
Hypovitaminosis DInsulin ResistanceDiabetes
Bastyr University 66
Not applicableLooking for participantsNCT06755372
What this trial is testing

The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Population

Who this might be right for
PeriodontitisEnd-stage Renal Disease
Ain Shams University 100
Testing effectiveness (Phase 2)Study completedNCT00220805
What this trial is testing

Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Grifols Therapeutics LLC 96
Post-approval studies (Phase 4)Study completedNCT01986907
What this trial is testing

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

Who this might be right for
Wet Age Related Macular Degeneration
Novartis Pharmaceuticals 1,049

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation